CIM
ARLZ

Contrarius Investment Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Contrarius Investment Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-216,211
Closed -$495K – 66
2017
Q3 		$495K Hold
216,211
– – 0.03% 59
2017
Q2 		$292K Hold
216,211
– – 0.02% 53
2017
Q1 		$463K Sell
216,211
-18,963
-8% -$71.3K 0.03% 52
2016
Q4 		$1.04M Sell
235,174
-21,957
-9% -$104K 0.08% 47
2016
Q3 		$1.25M Sell
257,131
-41,424
-14% -$189K 0.09% 53
2016
Q2 		$985K Sell
298,555
-111,201
-27% -$420K 0.08% 53
2016
Q1 		$1.46M Buy
+409,756
New +$2.11M 0.13% 46

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.44B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return